SlideShare a Scribd company logo
1 of 12
1
•   Joint venture of Natura, Centroflora and Orsa Florestal


•   Offers comprehensive range of services fueled by Brazil’s
    extensive biodiversity, including: Development of innovative
    concepts, technologies and product prototypes for commercial
    use
•   Markets addressed: Cosmeceuticals, Nutraceuticals,
    Pharmaceuticals, Animal Health




                                         2
Shareholders                     Board
 Peter Andersen                Peter Andersen
Centroflora Amoroso            Centrofloras Garcia




                              Marcelo V Achoa
                                                       Assistant
                                                       Finance


           Innovation Team              KM          Administrative


             Cristina Ropke   Claudia Carvalho       Adrinana Silva

             Tânina Sawada

             Paulo Carvalho
                                   Isabelle Vidal


                               3
• Strong R&D team   • Ethnobotany studies            •   Proof of concept        •   Sound base of leading
                    • Potential of application                                       industry players
                                                     •   Safety and efficacy -
                    •   Regulatory issues            in vitro assays
                    •   Sustainability               •   Customized project
                                                     management tool
                                                     •   Proprietary projects)




                                                 4
Viability
         -Technical
         - Scientific                 Authorization                Desk Research
       - Commercial                   IBAMA/CGEN




IDEA                 Project Briefing                 Project Execution
                     -Desk Research                     - Safety Tests
                 - Choice of plants species            - Efficacy tests
               - Definition of test Protocols           - Formulation
                      - Chronogram                       - Develop.
                                                       - Stabiity Tests




                                        5
Viability
         -Technical
         - Scientific                 Authorization                Desk Research
       - Commercial                   IBAMA/CGEN




IDEA                 Project Briefing                 Project Execution
                     -Desk Research                     - Safety Tests
                 - Choice of plants species            - Efficacy tests
               - Definition of test Protocols           - Formulation
                      - Chronogram                       - Develop.
                                                       - Stabiity Tests




                                        5
MAPPING YBIOS COMPETICION BASEAD IN:

   Current strategy
   Core Competencies
   Industries covered

Identifying means to improve and to clarify external
 communication of Ybios activities in order to spread its
 work concept.

Suggesting communication tools to implement ideaof
linking customers to service suppliers enabling revenues
to Ybios.




                                           6
INFORMATION SOURCES


Data and trends used in this presentation were obtained from
various articles, documented interviews with herbal products
specialists and executives and others at leading herbal and
pharmaceutical companies that have products widely.


METHODOLOGY

 The base year for this report is 2008. Figures used are based on
 revenue numbers at the manufacturers' level and are taken form
 various professional research reports (BCC Research,Freedonia).




                                         7
INFORMATION SOURCES


Data and trends used in this presentation were obtained from
various articles, documented interviews with herbal products
specialists and executives and others at leading herbal and
pharmaceutical companies that have products widely used within
industry, or which have products in development for these
markets




                                          8
9
•   Personal Care Market in US generated $2 billion (2008)

•   Cosmeceutical market grows at about $5.8 billion annually

•   Use of botanicals grew 8% in US and Europe (2008)

•   Demand for cosmeceuticals in US to increase 7.4% annually
    through 2012

•   Sales of anti-aging skin care products, $1.6 billion in 2008,
    expected 20% sales growth through 2013

•   1 out of 7 (16%) of global beauty product launches was organic,
    ethical or all-natural (2008)



                                  10
11

More Related Content

What's hot

Brandwood cimdr 2015 biological safety risk management en
Brandwood cimdr 2015 biological safety risk management   enBrandwood cimdr 2015 biological safety risk management   en
Brandwood cimdr 2015 biological safety risk management enBrandwoodbiomedical
 
CDMO & CRO Outsourcing Guide for Emerging Pharma & Biotech Companies
CDMO & CRO Outsourcing Guide for Emerging Pharma & Biotech CompaniesCDMO & CRO Outsourcing Guide for Emerging Pharma & Biotech Companies
CDMO & CRO Outsourcing Guide for Emerging Pharma & Biotech CompaniesIrach Taraporewala
 
Thermo Fisher Introduction
Thermo Fisher IntroductionThermo Fisher Introduction
Thermo Fisher IntroductionKim Bunt
 
Webinar: Post Approval Changes in Biologics Manufacturing - A Practical Asses...
Webinar: Post Approval Changes in Biologics Manufacturing - A Practical Asses...Webinar: Post Approval Changes in Biologics Manufacturing - A Practical Asses...
Webinar: Post Approval Changes in Biologics Manufacturing - A Practical Asses...MilliporeSigma
 
Biomarker Exchange Standards
Biomarker Exchange StandardsBiomarker Exchange Standards
Biomarker Exchange StandardsPistoia Alliance
 
Legochem Company ppt
Legochem Company pptLegochem Company ppt
Legochem Company ppttheeastrd
 
Cpo cmo serialization back to school
Cpo cmo  serialization back to schoolCpo cmo  serialization back to school
Cpo cmo serialization back to schoolMichael Stewart
 
Innovotech Investor Presentation December 1, 2010
Innovotech Investor Presentation December 1, 2010Innovotech Investor Presentation December 1, 2010
Innovotech Investor Presentation December 1, 2010Innovotech Inc.
 
Lsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09aLsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09aandrewjroche
 

What's hot (10)

Brandwood cimdr 2015 biological safety risk management en
Brandwood cimdr 2015 biological safety risk management   enBrandwood cimdr 2015 biological safety risk management   en
Brandwood cimdr 2015 biological safety risk management en
 
CDMO & CRO Outsourcing Guide for Emerging Pharma & Biotech Companies
CDMO & CRO Outsourcing Guide for Emerging Pharma & Biotech CompaniesCDMO & CRO Outsourcing Guide for Emerging Pharma & Biotech Companies
CDMO & CRO Outsourcing Guide for Emerging Pharma & Biotech Companies
 
Thermo Fisher Introduction
Thermo Fisher IntroductionThermo Fisher Introduction
Thermo Fisher Introduction
 
Webinar: Post Approval Changes in Biologics Manufacturing - A Practical Asses...
Webinar: Post Approval Changes in Biologics Manufacturing - A Practical Asses...Webinar: Post Approval Changes in Biologics Manufacturing - A Practical Asses...
Webinar: Post Approval Changes in Biologics Manufacturing - A Practical Asses...
 
Bio-XL May 2017
Bio-XL May 2017Bio-XL May 2017
Bio-XL May 2017
 
Biomarker Exchange Standards
Biomarker Exchange StandardsBiomarker Exchange Standards
Biomarker Exchange Standards
 
Legochem Company ppt
Legochem Company pptLegochem Company ppt
Legochem Company ppt
 
Cpo cmo serialization back to school
Cpo cmo  serialization back to schoolCpo cmo  serialization back to school
Cpo cmo serialization back to school
 
Innovotech Investor Presentation December 1, 2010
Innovotech Investor Presentation December 1, 2010Innovotech Investor Presentation December 1, 2010
Innovotech Investor Presentation December 1, 2010
 
Lsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09aLsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09a
 

Viewers also liked

C:\documents and settings\yvalenra\mis documentos\yola privado\vii semestre\i...
C:\documents and settings\yvalenra\mis documentos\yola privado\vii semestre\i...C:\documents and settings\yvalenra\mis documentos\yola privado\vii semestre\i...
C:\documents and settings\yvalenra\mis documentos\yola privado\vii semestre\i...yvalenra
 
CK Elementary Tutoring Fall 2010 Newsletter
CK  Elementary  Tutoring  Fall 2010  NewsletterCK  Elementary  Tutoring  Fall 2010  Newsletter
CK Elementary Tutoring Fall 2010 Newslettermdaggnorman
 
B2 Sound Projects 2000 - 2010
B2 Sound Projects 2000 - 2010B2 Sound Projects 2000 - 2010
B2 Sound Projects 2000 - 2010Haris Ladopoulos
 
Sarnia-Lambton Elementary Tutoring Fall 2010 Newsletter
Sarnia-Lambton Elementary Tutoring Fall 2010 NewsletterSarnia-Lambton Elementary Tutoring Fall 2010 Newsletter
Sarnia-Lambton Elementary Tutoring Fall 2010 Newslettermdaggnorman
 
My circle of friends
My circle of friendsMy circle of friends
My circle of friendsyvalenra
 
B1 Sound Projects 2000 - 2010
B1 Sound Projects 2000 - 2010B1 Sound Projects 2000 - 2010
B1 Sound Projects 2000 - 2010Haris Ladopoulos
 
A2 sound projects 2000 - 2010
A2 sound projects 2000 - 2010A2 sound projects 2000 - 2010
A2 sound projects 2000 - 2010Haris Ladopoulos
 
Portal4everybody2010
Portal4everybody2010Portal4everybody2010
Portal4everybody2010Karel Charvat
 
A1 sound projects 2000 - 2010
A1 sound projects 2000 - 2010A1 sound projects 2000 - 2010
A1 sound projects 2000 - 2010Haris Ladopoulos
 
Creating Challenge Defense Files
Creating Challenge Defense FilesCreating Challenge Defense Files
Creating Challenge Defense Filesbwestes
 
Make Some Noise –What kind of Noise are YOU making? Engaging, Embracing and ...
Make Some Noise –What kind of Noise are YOU making?  Engaging, Embracing and ...Make Some Noise –What kind of Noise are YOU making?  Engaging, Embracing and ...
Make Some Noise –What kind of Noise are YOU making? Engaging, Embracing and ...bwestes
 
Tatsuya Loves Lauren!
Tatsuya Loves  Lauren!Tatsuya Loves  Lauren!
Tatsuya Loves Lauren!Tats12
 
Dolcevitamktinfantil
DolcevitamktinfantilDolcevitamktinfantil
DolcevitamktinfantilFlavia Alves
 
Brinde Jornalistas - Electrolux
Brinde Jornalistas - ElectroluxBrinde Jornalistas - Electrolux
Brinde Jornalistas - ElectroluxFlavia Alves
 
Cefalea y embarazo
Cefalea y embarazoCefalea y embarazo
Cefalea y embarazolaloenf
 

Viewers also liked (19)

C:\documents and settings\yvalenra\mis documentos\yola privado\vii semestre\i...
C:\documents and settings\yvalenra\mis documentos\yola privado\vii semestre\i...C:\documents and settings\yvalenra\mis documentos\yola privado\vii semestre\i...
C:\documents and settings\yvalenra\mis documentos\yola privado\vii semestre\i...
 
CK Elementary Tutoring Fall 2010 Newsletter
CK  Elementary  Tutoring  Fall 2010  NewsletterCK  Elementary  Tutoring  Fall 2010  Newsletter
CK Elementary Tutoring Fall 2010 Newsletter
 
Wish
WishWish
Wish
 
Wish
WishWish
Wish
 
B2 Sound Projects 2000 - 2010
B2 Sound Projects 2000 - 2010B2 Sound Projects 2000 - 2010
B2 Sound Projects 2000 - 2010
 
Sarnia-Lambton Elementary Tutoring Fall 2010 Newsletter
Sarnia-Lambton Elementary Tutoring Fall 2010 NewsletterSarnia-Lambton Elementary Tutoring Fall 2010 Newsletter
Sarnia-Lambton Elementary Tutoring Fall 2010 Newsletter
 
My circle of friends
My circle of friendsMy circle of friends
My circle of friends
 
B1 Sound Projects 2000 - 2010
B1 Sound Projects 2000 - 2010B1 Sound Projects 2000 - 2010
B1 Sound Projects 2000 - 2010
 
Process Model
Process ModelProcess Model
Process Model
 
A2 sound projects 2000 - 2010
A2 sound projects 2000 - 2010A2 sound projects 2000 - 2010
A2 sound projects 2000 - 2010
 
Portal4everybody2010
Portal4everybody2010Portal4everybody2010
Portal4everybody2010
 
A1 sound projects 2000 - 2010
A1 sound projects 2000 - 2010A1 sound projects 2000 - 2010
A1 sound projects 2000 - 2010
 
Creating Challenge Defense Files
Creating Challenge Defense FilesCreating Challenge Defense Files
Creating Challenge Defense Files
 
Make Some Noise –What kind of Noise are YOU making? Engaging, Embracing and ...
Make Some Noise –What kind of Noise are YOU making?  Engaging, Embracing and ...Make Some Noise –What kind of Noise are YOU making?  Engaging, Embracing and ...
Make Some Noise –What kind of Noise are YOU making? Engaging, Embracing and ...
 
Tatsuya Loves Lauren!
Tatsuya Loves  Lauren!Tatsuya Loves  Lauren!
Tatsuya Loves Lauren!
 
Dolcevitamktinfantil
DolcevitamktinfantilDolcevitamktinfantil
Dolcevitamktinfantil
 
Brinde Jornalistas - Electrolux
Brinde Jornalistas - ElectroluxBrinde Jornalistas - Electrolux
Brinde Jornalistas - Electrolux
 
Dvkiosque
DvkiosqueDvkiosque
Dvkiosque
 
Cefalea y embarazo
Cefalea y embarazoCefalea y embarazo
Cefalea y embarazo
 

Similar to Apresentação Ybios

imc Research Introduction
imc Research Introductionimc Research Introduction
imc Research IntroductionimcResearch
 
Implementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated EnvironmentImplementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated EnvironmentTechWell
 
Cadila Corporate
Cadila CorporateCadila Corporate
Cadila CorporateUmesh
 
Pharma New Product Planning- Medical Affairs Report Summary
Pharma New Product Planning- Medical Affairs Report SummaryPharma New Product Planning- Medical Affairs Report Summary
Pharma New Product Planning- Medical Affairs Report SummaryMarty Daniel with ThunderActive
 
Phillips Medisize Ireland March 2013
Phillips Medisize Ireland March 2013Phillips Medisize Ireland March 2013
Phillips Medisize Ireland March 2013kevinludlow
 
PDA Annual Mtg 2012 - CAACB Talk
PDA Annual Mtg 2012 - CAACB TalkPDA Annual Mtg 2012 - CAACB Talk
PDA Annual Mtg 2012 - CAACB Talkmewiebe
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
IPR for Researchers ; 28 12-2018
IPR  for Researchers ; 28 12-2018IPR  for Researchers ; 28 12-2018
IPR for Researchers ; 28 12-2018Mohd Iqbal Mir
 
18 phi optics-i-corps-finalpresentation-draft
18   phi optics-i-corps-finalpresentation-draft18   phi optics-i-corps-finalpresentation-draft
18 phi optics-i-corps-finalpresentation-draftphioptics
 
Single Use Bioreactors (2012)
Single Use Bioreactors (2012)Single Use Bioreactors (2012)
Single Use Bioreactors (2012)shad121
 
4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) Pp4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) PpPiyush Patel
 
Warning Information Development Process
Warning Information Development ProcessWarning Information Development Process
Warning Information Development ProcessEric Shaver, PhD
 

Similar to Apresentação Ybios (20)

imc Research Introduction
imc Research Introductionimc Research Introduction
imc Research Introduction
 
Implementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated EnvironmentImplementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated Environment
 
Cadila Corporate
Cadila CorporateCadila Corporate
Cadila Corporate
 
Pharma New Product Planning- Medical Affairs Report Summary
Pharma New Product Planning- Medical Affairs Report SummaryPharma New Product Planning- Medical Affairs Report Summary
Pharma New Product Planning- Medical Affairs Report Summary
 
Presentation akshay lal
Presentation akshay lalPresentation akshay lal
Presentation akshay lal
 
Phillips Medisize Ireland March 2013
Phillips Medisize Ireland March 2013Phillips Medisize Ireland March 2013
Phillips Medisize Ireland March 2013
 
PDA Annual Mtg 2012 - CAACB Talk
PDA Annual Mtg 2012 - CAACB TalkPDA Annual Mtg 2012 - CAACB Talk
PDA Annual Mtg 2012 - CAACB Talk
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
Stabicon Corporate Presentation
Stabicon Corporate PresentationStabicon Corporate Presentation
Stabicon Corporate Presentation
 
Inserogen Lecture 4 Channels
Inserogen Lecture 4 ChannelsInserogen Lecture 4 Channels
Inserogen Lecture 4 Channels
 
IPR for Researchers ; 28 12-2018
IPR  for Researchers ; 28 12-2018IPR  for Researchers ; 28 12-2018
IPR for Researchers ; 28 12-2018
 
18 phi optics-i-corps-finalpresentation-draft
18   phi optics-i-corps-finalpresentation-draft18   phi optics-i-corps-finalpresentation-draft
18 phi optics-i-corps-finalpresentation-draft
 
Single Use Bioreactors (2012)
Single Use Bioreactors (2012)Single Use Bioreactors (2012)
Single Use Bioreactors (2012)
 
4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) Pp4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) Pp
 
Warning Information Development Process
Warning Information Development ProcessWarning Information Development Process
Warning Information Development Process
 
Warning Information Development Process
Warning Information Development ProcessWarning Information Development Process
Warning Information Development Process
 

More from Flavia Alves

campanha digital kassinski
campanha digital kassinskicampanha digital kassinski
campanha digital kassinskiFlavia Alves
 
Do Vivo Alimentação Viva
Do Vivo Alimentação VivaDo Vivo Alimentação Viva
Do Vivo Alimentação VivaFlavia Alves
 
CA TECNOLOGIES SOCIAL MÍDIA
CA TECNOLOGIES SOCIAL MÍDIACA TECNOLOGIES SOCIAL MÍDIA
CA TECNOLOGIES SOCIAL MÍDIAFlavia Alves
 
Apresentação Linha Criativa
Apresentação Linha CriativaApresentação Linha Criativa
Apresentação Linha CriativaFlavia Alves
 
Apresentação Filmes para Bailar
Apresentação Filmes para BailarApresentação Filmes para Bailar
Apresentação Filmes para BailarFlavia Alves
 
Apresentação Casa da Colina
Apresentação Casa da ColinaApresentação Casa da Colina
Apresentação Casa da ColinaFlavia Alves
 

More from Flavia Alves (7)

campanha digital kassinski
campanha digital kassinskicampanha digital kassinski
campanha digital kassinski
 
Do Vivo Alimentação Viva
Do Vivo Alimentação VivaDo Vivo Alimentação Viva
Do Vivo Alimentação Viva
 
CA TECNOLOGIES SOCIAL MÍDIA
CA TECNOLOGIES SOCIAL MÍDIACA TECNOLOGIES SOCIAL MÍDIA
CA TECNOLOGIES SOCIAL MÍDIA
 
Projeção
ProjeçãoProjeção
Projeção
 
Apresentação Linha Criativa
Apresentação Linha CriativaApresentação Linha Criativa
Apresentação Linha Criativa
 
Apresentação Filmes para Bailar
Apresentação Filmes para BailarApresentação Filmes para Bailar
Apresentação Filmes para Bailar
 
Apresentação Casa da Colina
Apresentação Casa da ColinaApresentação Casa da Colina
Apresentação Casa da Colina
 

Apresentação Ybios

  • 1. 1
  • 2. Joint venture of Natura, Centroflora and Orsa Florestal • Offers comprehensive range of services fueled by Brazil’s extensive biodiversity, including: Development of innovative concepts, technologies and product prototypes for commercial use • Markets addressed: Cosmeceuticals, Nutraceuticals, Pharmaceuticals, Animal Health 2
  • 3. Shareholders Board Peter Andersen Peter Andersen Centroflora Amoroso Centrofloras Garcia Marcelo V Achoa Assistant Finance Innovation Team KM Administrative Cristina Ropke Claudia Carvalho Adrinana Silva Tânina Sawada Paulo Carvalho Isabelle Vidal 3
  • 4. • Strong R&D team • Ethnobotany studies • Proof of concept • Sound base of leading • Potential of application industry players • Safety and efficacy - • Regulatory issues in vitro assays • Sustainability • Customized project management tool • Proprietary projects) 4
  • 5. Viability -Technical - Scientific Authorization Desk Research - Commercial IBAMA/CGEN IDEA Project Briefing Project Execution -Desk Research - Safety Tests - Choice of plants species - Efficacy tests - Definition of test Protocols - Formulation - Chronogram - Develop. - Stabiity Tests 5
  • 6. Viability -Technical - Scientific Authorization Desk Research - Commercial IBAMA/CGEN IDEA Project Briefing Project Execution -Desk Research - Safety Tests - Choice of plants species - Efficacy tests - Definition of test Protocols - Formulation - Chronogram - Develop. - Stabiity Tests 5
  • 7. MAPPING YBIOS COMPETICION BASEAD IN: Current strategy Core Competencies Industries covered Identifying means to improve and to clarify external communication of Ybios activities in order to spread its work concept. Suggesting communication tools to implement ideaof linking customers to service suppliers enabling revenues to Ybios. 6
  • 8. INFORMATION SOURCES Data and trends used in this presentation were obtained from various articles, documented interviews with herbal products specialists and executives and others at leading herbal and pharmaceutical companies that have products widely. METHODOLOGY The base year for this report is 2008. Figures used are based on revenue numbers at the manufacturers' level and are taken form various professional research reports (BCC Research,Freedonia). 7
  • 9. INFORMATION SOURCES Data and trends used in this presentation were obtained from various articles, documented interviews with herbal products specialists and executives and others at leading herbal and pharmaceutical companies that have products widely used within industry, or which have products in development for these markets 8
  • 10. 9
  • 11. Personal Care Market in US generated $2 billion (2008) • Cosmeceutical market grows at about $5.8 billion annually • Use of botanicals grew 8% in US and Europe (2008) • Demand for cosmeceuticals in US to increase 7.4% annually through 2012 • Sales of anti-aging skin care products, $1.6 billion in 2008, expected 20% sales growth through 2013 • 1 out of 7 (16%) of global beauty product launches was organic, ethical or all-natural (2008) 10
  • 12. 11

Editor's Notes